Lori Anne Kunkel
Insider
- 2025
- Jul 8, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Lori Anne Kunkel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $51.68M in ELVN purchases and sales in the last 12 months
- Mika K. Derynck - $9.56M in ELVN purchases and sales in the last 12 months
- Helen Louise Collins - $5.39M in ELVN purchases and sales in the last 12 months
- Joseph P. Lyssikatos - $4.71M in ELVN purchases and sales in the last 12 months
- Dominic Piscitelli - $1.95M in ORIC purchases and sales in the last 12 months
- Benjamin Hohl - $1.53M in ELVN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lori Anne Kunkel?
Lori Anne Kunkel is a corporate insider of Enliven Therapeutics, Inc. (ELVN). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Lori Anne Kunkel last file a Form 4?
The most recent primary Form 4 on record is dated 8 July 2026, one of 4 filings going back to 2025.
Has Lori Anne Kunkel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($850K) across all tracked filings.